A bipartisan effort to rein in prescription drug prices advanced Thursday as a key U.S. Senate committee approved a bill aimed at reforming pharmacy benefit managers.
PBMs are powerful middlemen who negotiate between drug companies and health insurers and can influence consumers’ and insurers’ costs for medications, patient access to drugs, and payment terms for pharmacies.
The…
This article was originally published by Marketwatch.com. Read the original article here.
